Karl Kreder, MD, MBA, has been named the head of the department of urology at the University of Iowa, Iowa City. He succeeds the late Richard Williams, MD, who led the department for more than 25 years.
Karl Kreder, MD, MBA, has been named the head of the department of urology at the University of Iowa, Iowa City. He succeeds the late Richard Williams, MD, who led the department for more than 25 years.
"Dr. Williams was an outstanding physician, researcher, and administrative leader," said Jean Robillard, MD, vice president for medical affairs at the University of Iowa. "He and Dr. Kreder worked closely together, and I am very pleased that Dr. Kreder has agreed to lead our tremendous faculty and staff in the department of urology."
Dr. Kreder, professor of urology, has served as vice chair in the department of urology and director of urodynamics and reconstructive urology. He joined the University of Iowa faculty in 1992 from Fitzsimons Army Medical Center in Aurora, CO. After leaving active duty, Dr. Kreder remained in the Army Reserves and retired from the U.S. Army after rising to the rank of colonel. He earned a medical degree from Georgetown University School of Medicine, Washington and completed an internship and residency in urology at Tripler Army Medical Center in Honolulu, and a fellowship in reconstructive urology at Duke University Medical Center in Durham, NC.
In addition to his clinical, research, and teaching activities, Dr. Kreder has served on departmental, collegiate, and university committees, and is a member of regional, national, and international professional organizations.
Dr. Chan on prevention, diagnosis, and treatment of kidney stones in pediatric patients
July 26th 2024"Stones that recur in children happen about 40% to 50% of the time. That's why the American Urological Association guidelines recommend doing a complete metabolic evaluation in all children," says Katherine Chan, MD, MPH.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.